Advertisement

miljoeansvarlig hordaland fylkeskommune Norwegian hepatitis C patients wait for treatment due to medicine monopoly: report

Share this article

Norwegian hepatitis C patients wait for treatment due to medicine monopoly: report
Photo: SimpleFoto/vacuum packing machine
14:07 CEST+02:00
Norwegian hepatitis C patients are waiting longer than they should for medical treatment due in part to a monopoly on its supply, according to a report.

tegn etter en tiger Between 15,000 and 20,000 Norwegians live with the chronic condition, which is treated with a 12-week course of medicine.

caroline kino program The cost of a 12-week course of the Epclusa medicine in Norway is 540,000 kroner (57,000 euros), according to the degrees to celsius newspaper.

læreplan naturfag påbygg American pharmaceutical company Gilead Sciences owns a monopoly on supply of the medicine in the Scandinavian country, according to the report.

bjerke urmaker nettbutikk The medicine, which can cure the disease, is not prescribed to patients with the type 2 and 3 forms of hepatitis C – around 60 percent of sufferers in Norway – until their livers show clear signs of damage.

konvertere mp3 fra youtube Although it can take many years from contracting the disease until the liver starts to fail, patients not given the treatment sooner are left with uncertain physical consequences as well as the psychological distress of living with the infectious condition, writes Klassekampen.

rettsinstanser i norge People with hepatitis C are not automatically entitled to the treatment, but are given it once symptoms are present.

åpen uselektert praksis Ronny Bjørnestad, head of NGO Prolar, which works to improve understanding of the illness, told Klassekampen that he had decided to obtain the treatment by going abroad.

gulvrenner i rustfritt stål “I felt I couldn't wait any longer. I have a ticking bomb in my liver and am still infectious. I have a teenager in my house and it wouldn't take any more than him accidentally using my razor blade for an accident to happen,” he told Klassekampen.

mycroft x lestrade fanart Bjørnestad said that he had purchased the same medicine for the equivalent of 7,500 kroner (800 euros) in Bangladesh, and then had it sent on to a friend in Scotland.

derry city sofifa It is legal for Bjørnestad to bring the medicine back to Norway provided he begins the course of treatment while in Scotland, writes Klassekampen.

witro bil fossegrenda “If it was an illness that [mainly] affected a group with stronger resources then this would never have been accepted,” he told the newspaper.

frakter våre selv til toll The disease has relatively high prevalence amongst former and active drug addicts.

mageli camping hytter Olav Dalgard, consultant at the department of infectious diseases at Akershus University Hospital, told Klassekampen that the price of Hepatitis C medicine in Norway is “amorally” high.

opphør av næringsvirksomhet moms “If we had cheaper medicine, we would recommend treatment of far more people at a much earlier stage. It would reduce the risk of disease spread. But prices must be reduced for that to be possible” Dalgard told Klassekampen.

bank filial nordea gran The newspaper has contacted Gilead Sciences for comment. 

country club casual dress code trenger hjelp med gjeld READ ALSO: mexico vehicle export by destinations

Get notified about breaking news on The Local
hva spiser katter

Share this article

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement